Andere Sprachen CURE BIOT OTC Markets

Aktien

A3DVW7

US23128N2071

CUBT

Markt geschlossen - OTC Markets Andere Börsenplätze 16:40:29 13.06.2024			% 5 Tage	% 1. Jan.
0,019 ^USD	0,00 %		+4,40 %	-10,80 %

06.05.	Curative Biotechnology, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
2023	Curative Biotechnology, Inc. hat seinen Börsengang in Höhe von $7,999998 Millionen zurückgezogen.	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06.05.
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors	22.03.
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors	08.01.
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	25.11.
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors	31.10.23
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	07.09.23
Curative Biotechnology, Inc. Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions	07.06.23
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions	06.06.23
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation	24.05.23
Curative Biotechnology, Inc. Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study	05.01.23
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study	05.01.23
Curative Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	16.11.22
Curative Biotechnology, Inc. has filed an IPO in the amount of $7.999998 million.	07.11.22
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $8 million.	31.10.22
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange	27.09.22
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange	27.09.22
Curative Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	01.09.22
Curative Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	29.06.22
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	16.06.22
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	16.06.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen CURE BIOT OTC Markets

Aktien

A3DVW7

US23128N2071

CUBT

Andere Sprachen

Filter